1. Heersink School of Medicine Division of Hematology & Oncology, University of Alabama, Birmingham, AL
2. Department of Medicine Section of Geriatrics and Palliative Medicine, Baylor College of Medicine, Houston, TX
3. Novo Nordisk Rare Disease, Zurich, Switzerland